Short-term safety and tolerability profile of 5-methoxy-N,N-dimethyltryptamine in human subjects: a systematic review of clinical trials

IntroductionPsychedelic agents have regained the attention of pharmaceutical companies as promising treatments for depressive episodes. 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT), an atypical psychedelic, is emerging as a potentially effective, novel rapid-acting antidepressant. In this systematic...

Bibliografiset tiedot
Päätekijät:	Aleksander Kwaśny, Alina Wilkowska, Wiesław Jerzy Cubała
Aineistotyyppi:	Artikkeli
Kieli:	English
Julkaistu:	Frontiers Media S.A. 2024-09-01
Sarja:	Frontiers in Psychiatry
Aiheet:	5-methoxy-N,N-dimethyltryptamine 5-MeO-DMT safety tolerability adverse events side effects
Linkit:	https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1477996/full

Samankaltaisia teoksia

Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon’s predictors and its emotional valence
Tekijä: Ana María Ortiz Bernal, et al.
Julkaistu: (2022-11-01)

5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study
Tekijä: Anya Ragnhildstveit, et al.
Julkaistu: (2023-11-01)

Cardiac effects of two hallucinogenic natural products, N,N-dimethyl-tryptamine and 5-methoxy-N,N-dimethyl-tryptamine
Tekijä: Joachim Neumann, et al.
Julkaistu: (2025-02-01)

Infoveillance and Critical Analysis of the Systematically Reviewed Literature on Dimethyltryptamine and the “God Molecule”
Tekijä: Ahmed Al-Imam, et al.
Julkaistu: (2023-06-01)

A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N,N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers
Tekijä: J. Reckweg, et al.
Julkaistu: (2022-06-01)

Indolethylamine-N-methyltransferase Polymorphisms: Genetic and Biochemical Approaches for Study of Endogenous N,N,-dimethyltryptamine
Tekijä: Jon G. Dean
Julkaistu: (2018-04-01)

A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression
Tekijä: Johannes T. Reckweg, et al.
Julkaistu: (2023-06-01)

Increased functional connectivity between brain regions involved in social cognition, emotion and affective-value in psychedelic states induced by N,N-Dimethyltryptamine (DMT)
Tekijä: Carla Soares, et al.
Julkaistu: (2024-10-01)

Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics
Tekijä: Cristiano Chaves, et al.
Julkaistu: (2024-11-01)

Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study
Tekijä: Joseph Barsuglia, et al.
Julkaistu: (2018-12-01)

N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function
Tekijä: Steven A. Barker
Julkaistu: (2018-08-01)

Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review
Tekijä: Gniewko Więckiewicz, et al.
Julkaistu: (2021-08-01)

This is your brain on death: a comparative analysis of a near-death experience and subsequent 5-Methoxy-DMT experience
Tekijä: Pascal Michael, et al.
Julkaistu: (2023-06-01)

5-MeO-DMT induces sleep-like LFP spectral signatures in the hippocampus and prefrontal cortex of awake rats
Tekijä: Annie C. Souza, et al.
Julkaistu: (2024-05-01)

Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy
Tekijä: Maria Eleni Eleftheriou, et al.
Julkaistu: (2021-08-01)

Rumors of Psychedelics, Psychotropics and Related Derivatives in <i>Vachellia</i> and <i>Senegalia</i> in Contrast with Verified Records in Australian <i>Acacia</i>
Tekijä: Nicholas J. Sadgrove
Julkaistu: (2022-12-01)

DMT Models the Near-Death Experience
Tekijä: Christopher Timmermann, et al.
Julkaistu: (2018-08-01)

Editorial: Down the rabbit hole – the psychological and neural mechanisms of psychedelic compounds and their use in treating mental health and medical conditions
Tekijä: Leehe Peled-Avron, et al.
Julkaistu: (2024-06-01)

Updated View on the Relation of the Pineal Gland to Autism Spectrum Disorders
Tekijä: Tal Shomrat, et al.
Julkaistu: (2019-02-01)

Marine Inspired 2-(5-Halo-1H-indol-3-yl)-N,N-dimethylethanamines as Modulators of Serotonin Receptors: An Example Illustrating the Power of Bromine as Part of the Uniquely Marine Chemical Space
Tekijä: Mohamed A. Ibrahim, et al.
Julkaistu: (2017-08-01)

Corrigendum: A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus
Tekijä: Rafael Vitor Lima da Cruz, et al.
Julkaistu: (2019-04-01)

A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus
Tekijä: Rafael Vitor Lima da Cruz, et al.
Julkaistu: (2018-09-01)

DMT alters cortical travelling waves
Tekijä: Andrea Alamia, et al.
Julkaistu: (2020-10-01)

Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial
Tekijä: Ellen James, et al.
Julkaistu: (2024-01-01)

N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer’s disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk
Tekijä: Dan Cheng, et al.
Julkaistu: (2024-05-01)

Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample
Tekijä: Tor-Morten Kvam, et al.
Julkaistu: (2023-11-01)

On the markers for schizophrenia
Tekijä: A. N. Erichev, et al.
Julkaistu: (2021-10-01)

QSPR study on pKa values of N-methoxy-polynitroaniline derivatives
Tekijä: Beteringhe Adrian
Julkaistu: (2005-12-01)

An encounter with death: a comparative thematic and content analysis of naturalistic DMT experiences and the near-death experience
Tekijä: Pascal Michael, et al.
Julkaistu: (2025-03-01)

An encounter with the self: A thematic and content analysis of the DMT experience from a naturalistic field study
Tekijä: Pascal Michael, et al.
Julkaistu: (2023-03-01)

Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-Dimethyltryptamine and harmine
Tekijä: Dario A. Dornbierer, et al.
Julkaistu: (2023-11-01)

Expanding the Scope of the Cleavable <i>N</i>-(Methoxy)oxazolidine Linker for the Synthesis of Oligonucleotide Conjugates
Tekijä: Aapo Aho, et al.
Julkaistu: (2021-01-01)

Potential therapeutic use of ayahuasca: A literature review
Tekijä: Salvana Priscylla Manso COSTA, et al.
Julkaistu: (2024-07-01)

Ayahuasca and Its DMT- and β-carbolines – Containing Ingredients Block the Expression of Ethanol-Induced Conditioned Place Preference in Mice: Role of the Treatment Environment
Tekijä: Elisangela G. Cata-Preta, et al.
Julkaistu: (2018-05-01)

3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an <sup>18</sup>F-FDG PET/CT Case Report
Tekijä: Maria Pepe, et al.
Julkaistu: (2024-03-01)

The endogenous hallucinogen and trace amine N,N-dimethyltryptamine (DMT) displays potent protective effects against hypoxia via sigma-1 receptor activation in human primary iPSC-derived cortical neurons and microglia-like immune cells
Tekijä: Attila Szabo, et al.
Julkaistu: (2016-09-01)

Dual actions of 5‐MeO‐DIPT at the serotonin transporter and serotonin 5‐HT1A receptor in the mouse striatum and prefrontal cortex
Tekijä: Yoko Hagino, et al.
Julkaistu: (2021-03-01)

Transcriptome-wide N6-methyladenosine methylation profile of atherosclerosis in mice
Tekijä: Xinbin Zheng, et al.
Julkaistu: (2023-12-01)

Fast Hollow Fiber Liquid-Phase Microextraction as a Greener Alternative for the Determination of N,N-Dimethyltryptamine and Harmala Alkaloids in Human Urine
Tekijä: Gabriela de Oliveira Silveira, et al.
Julkaistu: (2020-10-01)

Synthesis and Spectroscopic of Some new Metal Ions Complexes's with [N-(4-Methoxy Benzoyl Amino)-Thioxo Methyl] Leucine
Tekijä: Basima M. Sarhan, et al.
Julkaistu: (2017-04-01)